GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol
NCT00158899
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
424
Enrollment
INDUSTRY
Sponsor class
Conditions
Dyslipidaemias
Dyslipidaemia
Interventions
DRUG:
GW501516 oral tablets
Sponsor
GlaxoSmithKline